Israel21C notes that the Israel Stem Cell Therapy Consortium, a group of medical companies and academic research facilities, is now underway. The consortium is embarking on a $15-20 million program to develop the tools and techniques for widespread development of stem cell based therapies. This is the sort of initiative that we need to see more of elsewhere in the world: determined, sensible, well-planned steps towards creating the healthy life extension medicine of the future. The will is there in the US and Europe, but current and pending anti-research legislation is scaring away funding and investment.
[Editor: The preceding article was not written by A4M/WHN]
